GENMAB A/S (GMAB) Form 10-Q Quarterly Reports
GENMAB A/S (GMAB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GMAB
CIK: 1434265
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte Statsautoriseret Revisionspartnerselskab
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerNiels Vendelbo
Audit LocationCopenhagen, Denmark
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-13 | 2026-10-13 | 6-K | 0001434265-26-000136 | View SEC Doc Filr Page |
| 6-K | 2026-10-07 | 2026-10-07 | 6-K | 0001434265-26-000134 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-05 | — | SCHEDULE 13G Filing | 0000902664-26-004067 | View SEC Doc Filr Page |
| 6-K | 2026-10-05 | 2026-10-05 | 6-K | 0001434265-26-000132 | View SEC Doc Filr Page |
| 6-K | 2026-10-02 | 2026-10-02 | 6-K | 0001434265-26-000129 | View SEC Doc Filr Page |
| 6-K | 2026-09-29 | 2026-09-29 | 6-K | 0001434265-26-000127 | View SEC Doc Filr Page |
| 6-K | 2026-09-24 | 2026-09-24 | 6-K | 0001434265-26-000125 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-09 | 6-K | 0001434265-26-000123 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-08 | 6-K | 0001434265-26-000120 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-08 | 6-K | 0001434265-26-000116 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000940594-26-000043 | View SEC Doc Filr Page |
| 6-K | 2026-08-12 | 2026-08-12 | 6-K | 0001434265-26-000113 | View SEC Doc Filr Page |
| 6-K | 2026-08-11 | 2026-08-11 | 6-K | 0001434265-26-000111 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-06-30 | 6-K | 0001434265-26-000108 | View SEC Doc Filr Page |
| 6-K | 2026-07-15 | 2026-07-15 | 6-K | 0001434265-26-000102 | View SEC Doc Filr Page |
| 6-K | 2026-06-29 | 2026-06-29 | 6-K | 0001434265-26-000100 | View SEC Doc Filr Page |
| 6-K | 2026-06-17 | 2026-06-17 | 6-K | 0001434265-26-000097 | View SEC Doc Filr Page |
| 6-K | 2026-06-16 | 2026-06-16 | 6-K | 0001434265-26-000094 | View SEC Doc Filr Page |
| 6-K | 2026-06-15 | 2026-06-15 | 6-K | 0001434265-26-000092 | View SEC Doc Filr Page |
| 6-K | 2026-06-15 | 2026-06-15 | 6-K | 0001434265-26-000090 | View SEC Doc Filr Page |
| 6-K | 2026-06-11 | 2026-06-11 | 6-K | 0001434265-26-000087 | View SEC Doc Filr Page |
| 6-K | 2026-05-29 | 2026-05-29 | 6-K | 0001434265-26-000085 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000940594-26-000029 | View SEC Doc Filr Page |
| 6-K | 2026-05-13 | 2026-05-13 | 6-K | 0001434265-26-000083 | View SEC Doc Filr Page |
| 6-K | 2026-05-12 | 2026-05-12 | 6-K | 0001434265-26-000081 | View SEC Doc Filr Page |